Pathological autoantibodies in cardiomyopathy
- 1 January 2008
- journal article
- review article
- Published by Taylor & Francis Ltd in Autoimmunity
- Vol. 41 (6), 454-461
- https://doi.org/10.1080/08916930802031603
Abstract
Myocardial dilatation and dysfunction in the absence of significant coronary heart disease has been termed "idiopathic" dilated cardiomyopathy (iDCM), which--according to the 1995 task force report on the classification of cardiomyopathies-besides genetic, toxic or infectious causes also includes immune-mediated heart muscle damage in the spectrum of putative DCM etiologies. Incremental research on this topic particularly in the past few years has significantly contributed evidence to the hypothesis that autoimmune reactions against certain myocyte antigens may play a pivotal role in the initiation and/or progression of DCM. Recent transfer experiments in animals (mostly rodents) performed by various groups throughout the world and some preliminary clinical data even indicate that a few of these autoantibodies are indeed "pathogenic", inferring that they can actually cause cardiac dysfunction and heart failure by their own. Dependent on the individual genetic predisposition such harmful autoimmune reactions are supposed to emerge as a consequence of heart muscle damage induced by viral triggers, ischemia or exposure to cardiotoxins leading to myocyte apoptosis (and/or necrosis) and subsequent liberation of a "critical amount" of self-antigens previously hidden to the immune system. The following article will summarize the so far available evidence for an implication of a confined number of harmful autoantibodies directed against specific cardiac antigens in the pathogenesis of DCM.Keywords
This publication has 66 references indexed in Scilit:
- Cardiac Troponin I but Not Cardiac Troponin T Induces Severe Autoimmune Inflammation in the MyocardiumCirculation, 2006
- Removal of Pathogenic Autoantibodies by ImmunoadsorptionAnnals of the New York Academy of Sciences, 2005
- Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathyEuropean Heart Journal, 2004
- New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapyAutoimmunity Reviews, 2004
- Familial clustering of autoimmune diseases in patients with dilated cardiomyopathyThe American Journal of Cardiology, 2004
- Structural basis of autoimmunity against G protein coupled membrane receptorsInternational Journal of Cardiology, 1996
- Autoimmunity in dilated cardiomyopathy and the major histocompatibility complexInternational Journal of Cardiology, 1996
- β1-Adrenoceptor autoimmunity in cardiomyopathyInternational Journal of Cardiology, 1996
- Dilated Cardiomyopathy Defines Serum Autoantibodies Against G-Protein-Coupled Cardiovascular ReceptorsAutoimmunity, 1995
- Assessment of immune modulation of β-adrenergic pathways in human dilated cardiomyopathy: Influence of methodologic factorsAmerican Heart Journal, 1992